Harm ReductionPERRCEPNCT06894589
Assessment of the Perceptions and Opinions of Staff Working of Prisons and Detention Centers on the Use of Psychoactive Substances in Prisons and Harm Reduction (PERRCEP)
An observational study of Harm Reduction and Prisoners, run by University Hospital, Brest at 1 site in France.
Trial summary
Evaluation, through an anonymous questionnaire, of the perceptions and opinions of staff working in prisons and detention centers in Brittany regarding the consumption of illicit substances and harm reduction measures in prison environment. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Harm Reduction, Prisoners
- How many people
- 800 participants
- Where
- 1 siteFrance
- Study dates
- 1 Oct 2024to 1 May 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Working person of remand center of Brest, Vannes, Rennes, Saint-Malo, Lorient and Saint-Brieuc, and detention center of Lorient and Rennes : * healthcare staff, divided into 5 sectors : somatic, psychiatric, odontology, addictology, pharmacy) * prison warders * Reintegration support service (in french : Service pénitentiaire d'insertion et de probation) * other prison staff
Who may be able to join
- working person of remand center of Brest, Vannes, Rennes, Saint-Malo, Lorient and Saint-Brieuc, who has answered the questionnaire
- working person of detention center of Lorient and Rennes, who answered the questionnaire
Who cannot join
- person opposing participation in the study
- person under legal protection measure
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Assessment of the Perceptions and Opinions of Staff Working in Prisons and Detention Centers on the Use of Psychoactive Substances in Prisons and Harm Reduction
Evaluation, through an anonymous questionnaire, of the perceptions and opinions of staff working in prisons and detention centers in Brittany regarding the consumption of illicit substances and harm reduction measures in prison environment. The secondary objective of the study will be to assess training needs and explore factors associated with better adherence to the implementation of harm reduction measures.
Read the detailed description
A first contact will be made by email with the heads of institutions, directors of Penitentiary Rentegration Services), and coordinating doctors of healthcare units to inform them about the study's objectives and procedures, and to request their institution's and service's participation.
If they agree to participate, volunteer key contacts will be identified in each institution to relay the information to the staff working in the institution and ensure the distribution of the questionnaire.
The study's responsible doctor will meet with one of the resident investigators for a preliminary informational meeting with the institution's director, the SPIP director, and the identified key staff members. The questionnaires will be handed to the key contacts at that time.
A "non-opposition" letter will be individually distributed with each anonymous questionnaire to provide further details about the study for which their participation is requested.
After answering, participants will be able to place the questionnaire in the provided envelope, and then into a sealed ballot box.
After the answering period, the investigator will go back to prisons and detention centers to collect the ballot boxes.
The data from each paper questionnaire will be transcribed by the residents onto an online platform using the Lime Survey® software.
The statistician of UBO (university of Brest) will have access to the data on Lime Survey® in order to perform the statistical analyses as described below.
The statistician will make a descriptive analysis of the results and the an analytical study will research factors associated with improved adherence to harm reduction mesures : profession exercised; seniority; harm reduction training; age
- Conditions
- Harm Reduction, Prisoners
- Medical subject headings
- Harm Reduction
What is being measured
The primary outcome is the main question the study is designed to answer.
perceptions and opinions of staff working in prisons and detention centers in Brittany regarding the consumption of illicit substances and harm reduction measures.
descriptive analysis of the results
Measured: from january 2025 to may 2025
Secondary outcomes (1)
Assess training needs and research factors associated with improved adherence to harm reduction mesures
An analytical study will research factors associated with improved adherence to harm reduction mesures : profession exercised; seniority; harm reduction training; age.
Measured: from january 2025 to may 2025
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Mar 2025
- Study start1 Oct 2024
- Primary completion1 May 2025 (estimated)
- Study completion1 May 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Harm ReductionStudies of the same condition, open and under way.
- More trials run by University Hospital, BrestThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 800 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Brest
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06894589
- Sponsor's protocol ID
- 29BRC24.0333 - PERRCEP
- Acronym
- PERRCEP
- Status last verified
- Jan 2025
- First submitted
- 19 Mar 2025
- Last updated
- 25 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: All collected data that underlie results in a publication
Study at a glance
From the registry record, last updated by the sponsor on 25 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of the Perceptions and Opinions of Staff Working in Prisons and Detention Centers on the Use of Psychoactive Substances in Prisons and Harm Reduction
- ClinicalTrials.gov ID
- NCT06894589
- Acronym / sponsor ID
- PERRCEP / 29BRC24.0333 - PERRCEP
- Conditions
- Harm Reduction, Prisoners
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 800 participants (estimated)
- Lead sponsor
- University Hospital, BrestUniversity, hospital or other
- Study start
- 1 Oct 2024 (actual)
- Primary completion
- 1 May 2025 (estimated)
- Study completion
- 1 May 2025 (estimated)
- First posted
- 25 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Evaluation, through an anonymous questionnaire, of the perceptions and opinions of staff working in prisons and detention centers in Brittany regarding the consumption of illicit substances and harm reduction measures in prison environment. The secondary objective of the study will be to assess training needs and explore factors associated with better adherence to the implementation of harm reduction measures.
Detailed description
A first contact will be made by email with the heads of institutions, directors of Penitentiary Rentegration Services), and coordinating doctors of healthcare units to inform them about the study's objectives and procedures, and to request their institution's and service's participation.
If they agree to participate, volunteer key contacts will be identified in each institution to relay the information to the staff working in the institution and ensure the distribution of the questionnaire.
The study's responsible doctor will meet with one of the resident investigators for a preliminary informational meeting with the institution's director, the SPIP director, and the identified key staff members. The questionnaires will be handed to the key contacts at that time.
A "non-opposition" letter will be individually distributed with each anonymous questionnaire to provide further details about the study for which their participation is requested.
After answering, participants will be able to place the questionnaire in the provided envelope, and then into a sealed ballot box.
After the answering period, the investigator will go back to prisons and detention centers to collect the ballot boxes.
The data from each paper questionnaire will be transcribed by the residents onto an online platform using the Lime Survey® software.
The statistician of UBO (university of Brest) will have access to the data on Lime Survey® in order to perform the statistical analyses as described below.
The statistician will make a descriptive analysis of the results and the an analytical study will research factors associated with improved adherence to harm reduction mesures : profession exercised; seniority; harm reduction training; age
Study design
- Observational model
- Other
- Time perspective
- Other
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Working person of remand center of Brest, Vannes, Rennes, Saint-Malo, Lorient and Saint-Brieuc, and detention center of Lorient and Rennes : * healthcare staff, divided into 5 sectors : somatic, psychiatric, odontology, addictology, pharmacy) * prison warders * Reintegration support service (in french : Service pénitentiaire d'insertion et de probation) * other prison staff
Key inclusion criteria (2 listed)
- working person of remand center of Brest, Vannes, Rennes, Saint-Malo, Lorient and Saint-Brieuc, who has answered the questionnaire
- working person of detention center of Lorient and Rennes, who answered the questionnaire
Key exclusion criteria (2 listed)
- person opposing participation in the study
- person under legal protection measure
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
perceptions and opinions of staff working in prisons and detention centers in Brittany regarding the consumption of illicit substances and harm reduction measures.
Time frame: from january 2025 to may 2025
descriptive analysis of the results
1 secondary outcome
Assess training needs and research factors associated with improved adherence to harm reduction mesures
Time frame: from january 2025 to may 2025
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Mar 2025.
- Individual participant dataSharing planned: Yes. All collected data that underlie results in a publication
Related trials for Harm Reduction
Not yet recruiting
Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
People Who Use Opioids/People With Opioid Use Disorder (OUD)
Not yet recruiting
Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition From the Emergency Department
Opioid Overdose Prevention, HIV Prevention and Care
Not yet recruiting
Examining the Effectiveness of a Brief Therapeutic Intervention for Reducing Self-Harm Among Adolescents
Self Injurious Behavior, Self Injurious Behavior Without Suicidal Intent
Not yet recruiting
Connecting Online Military Personnel to Alcohol Harm-reducing Smartphone Support Study
Alcohol Use Disorder (AUD)
Recruiting
STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
Tobacco Use, Substance Use Disorders
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Harm Reduction and Prisoners, run by University Hospital, Brest at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 25 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
perceptions and opinions of staff working in prisons and detention centers in Brittany regarding the consumption of illicit substances and harm reduction measures. (time frame: from january 2025 to may 2025). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Mar 2025.